A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.

For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated ...

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

As part of the pact, Sun Pharma will sell AstraZeneca's dapagliflozin, a Type 2 diabetes medicine, under brand name Oxra. AstraZeneca India markets dapagliflozin under the brand name Forxiga.